APA (7. basım) Alıntı

Kasner, S. E., Swaminathan, B., Lavados, P. M., Sharma, M., Muir, K. W., Veltkamp, R., . . . Baumgartner, P. (2018). Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial.

Chicago Style (17. basım) Atıf

Kasner, Scott E., et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial. 2018.

MLA (9th ed.) Atıf

Kasner, Scott E., et al. Rivaroxaban or Aspirin for Patent Foramen Ovale and Embolic Stroke of Undetermined Source: A Prespecified Subgroup Analysis from the NAVIGATE ESUS Trial. 2018.